| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | TTYH1 DCHS2 CDH23 ADGRV1 SVEP1 FAT1 PCDH15 UNC13B DSG3 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHB18P EYS HMCN1 MEGF8 PCDHGA12 PITPNM3 PADI6 DSG4 PCDHGA8 | 1.61e-10 | 749 | 192 | 29 | GO:0005509 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 CDH23 FAT1 PTPRF PKD1 PCDH15 SDK1 SDK2 DSG3 EMB PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHB18P HMCN1 TENM3 PCDHGA12 ROBO2 DSG4 PCDHGA8 | 1.46e-25 | 187 | 196 | 28 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 CDH23 LRRC4 FAT1 ADIPOQ PTPRF PKD1 PCDH15 SDK1 SDK2 DSG3 EMB PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 FAT3 PCDHB7 PCDHB4 PCDHB2 LRRC4B PCDHB18P HMCN1 TENM3 PCDHGA12 ROBO2 DSG4 PCDHGA8 CXADR | 8.16e-24 | 313 | 196 | 32 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB4 TTYH1 DCHS2 ITGA6 CDH23 ITGA2 ADGRV1 LRRC4 SVEP1 FAT1 ADIPOQ PTPRF PKD1 PCDH15 SDK1 SDK2 ZAN DSG3 EMB PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 FAT3 PCDHB7 PCDHB4 PCDHB2 LRRC4B TEK IGDCC4 PCDHB18P HHLA2 EFNB1 EFNB2 HMCN1 TENM3 PCDHGA12 CD44 CD58 ROBO2 DSG4 PCDHGA8 CXADR | 3.51e-18 | 1077 | 196 | 46 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell junction organization | MYOC ITGA6 ITGA2 CSMD2 LRRC4 MEF2C SVEP1 CHRNB1 PTPRF ABCC8 SDK1 UNC13B SDK2 PCDHB4 PCDHB2 LRRC4B NBEA TEK SHROOM2 EFNB1 EFNB2 TENM3 ROBO2 CXADR | 1.89e-05 | 974 | 196 | 24 | GO:0034330 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | EPHB4 EPOR TMEM67 ITGA6 CDH23 ITGA2 MEF2C MEF2D FAT1 PKD1 PCDH15 SDK1 IMPG2 SDK2 ADAMTS1 FAT3 WNT8A TEK SHROOM2 S1PR1 EFNB2 MEGF8 TENM3 BBS7 TP63 RBPJ CD44 ROBO2 | 2.73e-05 | 1269 | 196 | 28 | GO:0009887 |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 3.40e-05 | 20 | 196 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 3.88e-05 | 132 | 196 | 8 | GO:0043255 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 5.85e-05 | 71 | 196 | 6 | GO:0006111 | |
| GeneOntologyBiologicalProcess | kidney development | APH1B TMEM67 DCHS2 MEF2C FREM2 ADIPOQ PKD1 ADAMTS1 TEK SLC5A1 EFNB2 CD44 ROBO2 | 6.00e-05 | 372 | 196 | 13 | GO:0001822 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 6.81e-05 | 9 | 196 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | renal system development | APH1B TMEM67 DCHS2 MEF2C FREM2 ADIPOQ PKD1 ADAMTS1 TEK SLC5A1 EFNB2 CD44 ROBO2 | 8.70e-05 | 386 | 196 | 13 | GO:0072001 |
| GeneOntologyBiologicalProcess | gluconeogenesis | 9.27e-05 | 111 | 196 | 7 | GO:0006094 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 9.65e-05 | 10 | 196 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 1.16e-04 | 115 | 196 | 7 | GO:0019319 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid cell apoptotic process | 1.32e-04 | 11 | 196 | 3 | GO:0033034 | |
| GeneOntologyBiologicalProcess | carbohydrate biosynthetic process | B3GALT4 MAS1 RGPD1 PTH1R ERFE ADIPOQ SLC25A11 RANBP2 RGPD8 SIRT7 | 1.32e-04 | 247 | 196 | 10 | GO:0016051 |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 1.59e-04 | 121 | 196 | 7 | GO:0046364 | |
| GeneOntologyBiologicalProcess | synapse assembly | CSMD2 LRRC4 MEF2C SDK1 SDK2 PCDHB4 PCDHB2 LRRC4B EFNB1 EFNB2 ROBO2 | 1.84e-04 | 308 | 196 | 11 | GO:0007416 |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 2.25e-04 | 13 | 196 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 2.85e-04 | 14 | 196 | 3 | GO:1903299 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 4.53e-05 | 8 | 198 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | cell surface | EPOR MAS1 CD109 ITGA6 ITGA2 ADGRV1 ADIPOQ FCER1A PXDN MRC2 PKD1 SCNN1A NRDC TEK S1PR1 LIFR HHLA2 EFNB1 LNPEP FURIN CD44 CUZD1 CD58 ROBO2 CD151 | 5.34e-05 | 1111 | 198 | 25 | GO:0009986 |
| GeneOntologyCellularComponent | basal part of cell | ITGA6 ITGA2 PTH1R PKD1 SVOP ABCC10 ABCC1 RHBG TEK SLCO4C1 CD44 MTTP CXADR | 6.84e-05 | 378 | 198 | 13 | GO:0045178 |
| GeneOntologyCellularComponent | actin-based cell projection | TTYH1 ITGA6 CDH23 ADGRV1 FAT1 PCDH15 TEK CD44 CEACAM16 MTTP CXADR | 7.29e-05 | 278 | 198 | 11 | GO:0098858 |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 9.56e-05 | 10 | 198 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | basal plasma membrane | ITGA6 PTH1R PKD1 SVOP ABCC10 ABCC1 RHBG TEK SLCO4C1 CD44 MTTP CXADR | 1.49e-04 | 354 | 198 | 12 | GO:0009925 |
| GeneOntologyCellularComponent | basolateral plasma membrane | ITGA6 PTH1R PKD1 ABCC10 ABCC1 RHBG TEK SLCO4C1 CD44 MTTP CXADR | 2.50e-04 | 320 | 198 | 11 | GO:0016323 |
| GeneOntologyCellularComponent | annulate lamellae | 2.82e-04 | 14 | 198 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 6.15e-04 | 18 | 198 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 8.47e-04 | 20 | 198 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | cell projection membrane | TTYH1 TMEM67 ADGRV1 PTH1R PKD1 SCNN1A PSD3 SLC5A1 BBS7 CD44 MTTP ROBO2 | 8.71e-04 | 431 | 198 | 12 | GO:0031253 |
| GeneOntologyCellularComponent | SUMO ligase complex | 9.82e-04 | 21 | 198 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | basement membrane | 1.09e-03 | 122 | 198 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | interphotoreceptor matrix | 1.31e-03 | 6 | 198 | 2 | GO:0033165 | |
| GeneOntologyCellularComponent | receptor complex | EPHB4 ITGA6 ITGA2 ADGRV1 PTH1R CHRNB1 IMPG2 TRB TEK LIFR CD44 MTTP TRAV30 TRAV22 | 1.33e-03 | 581 | 198 | 14 | GO:0043235 |
| GeneOntologyCellularComponent | extracellular matrix | MYOC ITGA6 SVEP1 FREM2 ADIPOQ PXDN IMPG2 COL12A1 ZAN ADAMTS1 WNT8A EYS HMCN1 CD151 HCFC1 | 1.52e-03 | 656 | 198 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | MYOC ITGA6 SVEP1 FREM2 ADIPOQ PXDN IMPG2 COL12A1 ZAN ADAMTS1 WNT8A EYS HMCN1 CD151 HCFC1 | 1.56e-03 | 658 | 198 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | MYOC ITGA6 FREM2 ADIPOQ PXDN IMPG2 COL12A1 ADAMTS1 WNT8A EYS HMCN1 CD151 HCFC1 | 1.69e-03 | 530 | 198 | 13 | GO:0062023 |
| MousePheno | abnormal cardinal vein morphology | 1.00e-05 | 28 | 148 | 5 | MP:0004783 | |
| Domain | CA | DCHS2 CDH23 FREM2 FAT1 PCDH15 DSG3 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHGA12 DSG4 PCDHGA8 | 3.90e-19 | 115 | 194 | 20 | SM00112 |
| Domain | Cadherin | DCHS2 CDH23 FREM2 FAT1 PCDH15 DSG3 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHGA12 DSG4 PCDHGA8 | 6.67e-19 | 118 | 194 | 20 | IPR002126 |
| Domain | Cadherin_CS | DCHS2 CDH23 FAT1 PCDH15 DSG3 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHGA12 DSG4 PCDHGA8 | 2.98e-18 | 109 | 194 | 19 | IPR020894 |
| Domain | CADHERIN_1 | DCHS2 CDH23 FAT1 PCDH15 DSG3 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHGA12 DSG4 PCDHGA8 | 6.07e-18 | 113 | 194 | 19 | PS00232 |
| Domain | Cadherin | DCHS2 CDH23 FAT1 PCDH15 DSG3 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHGA12 DSG4 PCDHGA8 | 6.07e-18 | 113 | 194 | 19 | PF00028 |
| Domain | CADHERIN_2 | DCHS2 CDH23 FAT1 PCDH15 DSG3 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHGA12 DSG4 PCDHGA8 | 7.22e-18 | 114 | 194 | 19 | PS50268 |
| Domain | - | DCHS2 CDH23 FAT1 PCDH15 DSG3 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHGA12 DSG4 PCDHGA8 | 7.22e-18 | 114 | 194 | 19 | 2.60.40.60 |
| Domain | Cadherin-like | DCHS2 CDH23 FAT1 PCDH15 DSG3 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHGA12 DSG4 PCDHGA8 | 1.02e-17 | 116 | 194 | 19 | IPR015919 |
| Domain | Cadherin_C | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 PCDHB7 PCDHB4 PCDHB2 PCDHGA12 PCDHGA8 | 9.43e-15 | 42 | 194 | 12 | IPR032455 |
| Domain | Cadherin_C_2 | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 PCDHB7 PCDHB4 PCDHB2 PCDHGA12 PCDHGA8 | 9.43e-15 | 42 | 194 | 12 | PF16492 |
| Domain | Cadherin_2 | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 PCDHB7 PCDHB4 PCDHB2 PCDHGA12 PCDHGA8 | 2.79e-12 | 65 | 194 | 12 | PF08266 |
| Domain | Cadherin_N | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 PCDHB7 PCDHB4 PCDHB2 PCDHGA12 PCDHGA8 | 2.79e-12 | 65 | 194 | 12 | IPR013164 |
| Domain | Cadherin_tail | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8 | 1.13e-10 | 37 | 194 | 9 | PF15974 |
| Domain | Cadherin_CBD | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8 | 1.13e-10 | 37 | 194 | 9 | IPR031904 |
| Domain | Ig-like_fold | EPHB4 EPOR LRRC4 FCER1A PXDN PTPRF SDK1 SDK2 COL12A1 MID2 EMB TRB LRRC4B TEK IGDCC4 LIFR HHLA2 HMCN1 RBPJ CEACAM16 CD58 ROBO2 HCFC1 CXADR | 3.39e-07 | 706 | 194 | 24 | IPR013783 |
| Domain | - | EPHB4 EPOR LRRC4 FCER1A PXDN PTPRF SDK1 SDK2 COL12A1 MID2 EMB LRRC4B TEK IGDCC4 LIFR HHLA2 HMCN1 RBPJ CEACAM16 CD58 ROBO2 HCFC1 CXADR | 4.28e-07 | 663 | 194 | 23 | 2.60.40.10 |
| Domain | FN3 | EPHB4 EPOR PTPRF SDK1 SDK2 COL12A1 MID2 TEK IGDCC4 LIFR ROBO2 HCFC1 | 5.46e-07 | 185 | 194 | 12 | SM00060 |
| Domain | fn3 | EPHB4 EPOR PTPRF SDK1 SDK2 COL12A1 MID2 TEK IGDCC4 LIFR ROBO2 | 1.04e-06 | 162 | 194 | 11 | PF00041 |
| Domain | FN3 | EPHB4 EPOR PTPRF SDK1 SDK2 COL12A1 MID2 TEK IGDCC4 LIFR ROBO2 HCFC1 | 1.19e-06 | 199 | 194 | 12 | PS50853 |
| Domain | FN3_dom | EPHB4 EPOR PTPRF SDK1 SDK2 COL12A1 MID2 TEK IGDCC4 LIFR ROBO2 HCFC1 | 1.98e-06 | 209 | 194 | 12 | IPR003961 |
| Domain | EGF_2 | EPHB4 CNTNAP3B SVEP1 FAT1 C9 IMPG2 ZAN FAT3 TEK EYS HMCN1 MEGF8 TENM3 | 4.23e-06 | 265 | 194 | 13 | PS01186 |
| Domain | Ig_I-set | LRRC4 PXDN PTPRF SDK1 SDK2 EMB LRRC4B IGDCC4 HMCN1 ROBO2 CXADR | 4.94e-06 | 190 | 194 | 11 | IPR013098 |
| Domain | I-set | LRRC4 PXDN PTPRF SDK1 SDK2 EMB LRRC4B IGDCC4 HMCN1 ROBO2 CXADR | 4.94e-06 | 190 | 194 | 11 | PF07679 |
| Domain | Ran_BP1 | 5.23e-06 | 12 | 194 | 4 | PF00638 | |
| Domain | RANBD1 | 5.23e-06 | 12 | 194 | 4 | PS50196 | |
| Domain | Growth_fac_rcpt_ | 5.47e-06 | 156 | 194 | 10 | IPR009030 | |
| Domain | - | 6.59e-06 | 95 | 194 | 8 | 2.60.120.200 | |
| Domain | IGc2 | LRRC4 FCER1A PXDN PTPRF SDK1 SDK2 LRRC4B IGDCC4 HMCN1 CEACAM16 ROBO2 CXADR | 6.65e-06 | 235 | 194 | 12 | SM00408 |
| Domain | EGF_3 | CNTNAP3B SVEP1 FAT1 C9 IMPG2 ZAN FAT3 TEK EYS HMCN1 MEGF8 TENM3 | 6.65e-06 | 235 | 194 | 12 | PS50026 |
| Domain | Ig_sub2 | LRRC4 FCER1A PXDN PTPRF SDK1 SDK2 LRRC4B IGDCC4 HMCN1 CEACAM16 ROBO2 CXADR | 6.65e-06 | 235 | 194 | 12 | IPR003598 |
| Domain | RanBD | 7.50e-06 | 13 | 194 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 7.50e-06 | 13 | 194 | 4 | IPR000156 | |
| Domain | IG | LRRC4 FCER1A PXDN PTPRF SDK1 SDK2 EMB TRB LRRC4B IGDCC4 HHLA2 HMCN1 CEACAM16 CD58 ROBO2 CXADR | 8.76e-06 | 421 | 194 | 16 | SM00409 |
| Domain | Ig_sub | LRRC4 FCER1A PXDN PTPRF SDK1 SDK2 EMB TRB LRRC4B IGDCC4 HHLA2 HMCN1 CEACAM16 CD58 ROBO2 CXADR | 8.76e-06 | 421 | 194 | 16 | IPR003599 |
| Domain | EGF-like_dom | CNTNAP3B SVEP1 FAT1 C9 IMPG2 ZAN FAT3 TEK EYS HMCN1 MEGF8 TENM3 | 1.19e-05 | 249 | 194 | 12 | IPR000742 |
| Domain | EGF_1 | CNTNAP3B SVEP1 FAT1 C9 IMPG2 ZAN FAT3 TEK EYS HMCN1 MEGF8 TENM3 | 1.51e-05 | 255 | 194 | 12 | PS00022 |
| Domain | IG_LIKE | LRRC4 FCER1A PXDN PTPRF SDK1 SDK2 EMB TRB LRRC4B TEK IGDCC4 HHLA2 HMCN1 CEACAM16 CD58 ROBO2 CXADR | 1.53e-05 | 491 | 194 | 17 | PS50835 |
| Domain | ConA-like_dom | CNTNAP3B ADGRV1 ADGRG4 SVEP1 FAT1 COL12A1 ZAN MID2 FAT3 NBEA EYS | 1.89e-05 | 219 | 194 | 11 | IPR013320 |
| Domain | EGF-like_CS | EPHB4 SVEP1 FAT1 C9 IMPG2 ZAN FAT3 TEK EYS HMCN1 MEGF8 TENM3 | 1.91e-05 | 261 | 194 | 12 | IPR013032 |
| Domain | Ig-like_dom | LRRC4 FCER1A PXDN PTPRF SDK1 SDK2 EMB TRB LRRC4B TEK IGDCC4 HHLA2 HMCN1 CEACAM16 CD58 ROBO2 CXADR | 2.09e-05 | 503 | 194 | 17 | IPR007110 |
| Domain | Cyt_P450_E_CYP3A | 2.16e-05 | 6 | 194 | 3 | IPR008072 | |
| Domain | Vitellinogen_b-sht_N | 1.07e-04 | 2 | 194 | 2 | IPR015816 | |
| Domain | Lipid_transp_b-sht_shell | 1.07e-04 | 2 | 194 | 2 | IPR015819 | |
| Domain | - | 1.07e-04 | 2 | 194 | 2 | 2.30.230.10 | |
| Domain | VITELLOGENIN | 1.07e-04 | 2 | 194 | 2 | PS51211 | |
| Domain | LPD_N | 1.07e-04 | 2 | 194 | 2 | SM00638 | |
| Domain | Lipid_transpt_N | 1.07e-04 | 2 | 194 | 2 | IPR001747 | |
| Domain | - | 1.07e-04 | 2 | 194 | 2 | 1.25.10.20 | |
| Domain | Vitellogenin_N | 1.07e-04 | 2 | 194 | 2 | PF01347 | |
| Domain | Grip | 1.71e-04 | 11 | 194 | 3 | SM00755 | |
| Domain | GRIP | 1.71e-04 | 11 | 194 | 3 | PF01465 | |
| Domain | EGF | 1.80e-04 | 235 | 194 | 10 | SM00181 | |
| Domain | GRIP_dom | 2.27e-04 | 12 | 194 | 3 | IPR000237 | |
| Domain | GRIP | 2.27e-04 | 12 | 194 | 3 | PS50913 | |
| Domain | Kelch_2 | 2.92e-04 | 13 | 194 | 3 | IPR011498 | |
| Domain | Kelch_2 | 2.92e-04 | 13 | 194 | 3 | PF07646 | |
| Domain | Vitellinogen_superhlx | 3.20e-04 | 3 | 194 | 2 | IPR011030 | |
| Domain | Laminin_G | 3.37e-04 | 58 | 194 | 5 | IPR001791 | |
| Domain | EGF_Ca-bd_CS | 5.25e-04 | 97 | 194 | 6 | IPR018097 | |
| Domain | EGF_CA | 5.85e-04 | 99 | 194 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 6.17e-04 | 100 | 194 | 6 | PS00010 | |
| Domain | LAM_G_DOMAIN | 6.32e-04 | 38 | 194 | 4 | PS50025 | |
| Domain | Neural_cell_adh | 6.35e-04 | 4 | 194 | 2 | IPR009138 | |
| Domain | HJURP_C | 6.35e-04 | 4 | 194 | 2 | IPR022102 | |
| Domain | Desmoglein | 6.35e-04 | 4 | 194 | 2 | IPR009123 | |
| Domain | MADS_MEF2-like | 6.35e-04 | 4 | 194 | 2 | IPR033896 | |
| Domain | HJURP_C | 6.35e-04 | 4 | 194 | 2 | PF12347 | |
| Domain | Laminin_G_2 | 7.70e-04 | 40 | 194 | 4 | PF02210 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 8.39e-04 | 106 | 194 | 6 | IPR000152 | |
| Domain | Ammonium_transpt | 1.05e-03 | 5 | 194 | 2 | IPR001905 | |
| Domain | Cyt_P450_E_grp-II | 1.05e-03 | 5 | 194 | 2 | IPR002402 | |
| Domain | Ammonium_transp | 1.05e-03 | 5 | 194 | 2 | PF00909 | |
| Domain | NH4_transpt_AmtB-like_dom | 1.05e-03 | 5 | 194 | 2 | IPR024041 | |
| Domain | RhesusRHD | 1.05e-03 | 5 | 194 | 2 | IPR002229 | |
| Domain | LamG | 1.11e-03 | 44 | 194 | 4 | SM00282 | |
| Domain | Cupredoxin | 1.47e-03 | 22 | 194 | 3 | IPR008972 | |
| Domain | MADS_BOX_1 | 1.57e-03 | 6 | 194 | 2 | PS00350 | |
| Domain | Peptidase_S8_Asp-AS | 1.57e-03 | 6 | 194 | 2 | IPR023827 | |
| Domain | MADS | 1.57e-03 | 6 | 194 | 2 | SM00432 | |
| Domain | SRF-TF | 1.57e-03 | 6 | 194 | 2 | PF00319 | |
| Domain | MADS_BOX_2 | 1.57e-03 | 6 | 194 | 2 | PS50066 | |
| Domain | EGF_CA | 1.73e-03 | 122 | 194 | 6 | SM00179 | |
| Domain | CUB | 1.79e-03 | 50 | 194 | 4 | SM00042 | |
| Domain | EGF-like_Ca-bd_dom | 1.88e-03 | 124 | 194 | 6 | IPR001881 | |
| Domain | ABC_membrane | 1.90e-03 | 24 | 194 | 3 | PF00664 | |
| Domain | EGF_CA | 2.03e-03 | 86 | 194 | 5 | PF07645 | |
| Domain | - | 2.07e-03 | 52 | 194 | 4 | 2.60.120.290 | |
| Domain | Desmosomal_cadherin | 2.18e-03 | 7 | 194 | 2 | IPR009122 | |
| Domain | P_proprotein | 2.18e-03 | 7 | 194 | 2 | PF01483 | |
| Domain | Rab_bind | 2.18e-03 | 7 | 194 | 2 | PF16704 | |
| Domain | S8_pro-domain | 2.18e-03 | 7 | 194 | 2 | IPR032815 | |
| Domain | TF_MADSbox | 2.18e-03 | 7 | 194 | 2 | IPR002100 | |
| Domain | PrprotnconvertsP | 2.18e-03 | 7 | 194 | 2 | IPR002884 | |
| Domain | GCC2_Rab_bind | 2.18e-03 | 7 | 194 | 2 | IPR032023 | |
| Domain | - | 2.18e-03 | 7 | 194 | 2 | 1.10.3430.10 | |
| Domain | Ammonium/urea_transptr | 2.18e-03 | 7 | 194 | 2 | IPR029020 | |
| Domain | - | 2.18e-03 | 7 | 194 | 2 | 3.30.70.850 | |
| Domain | S8_pro-domain | 2.18e-03 | 7 | 194 | 2 | PF16470 | |
| Domain | CUB | 2.22e-03 | 53 | 194 | 4 | PS01180 | |
| Domain | Cys-rich_flank_reg_C | 2.47e-03 | 90 | 194 | 5 | IPR000483 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 PCDHB7 PCDHB4 PCDHB2 PCDHB18P PCDHGA12 PCDHGA8 | 1.13e-16 | 68 | 199 | 13 | 11230163 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 PCDHB7 PCDHB4 PCDHB2 PCDHB18P PCDHGA12 PCDHGA8 | 2.50e-16 | 72 | 199 | 13 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 PCDHB7 PCDHB4 PCDHB2 PCDHB18P PCDHGA12 PCDHGA8 | 3.65e-16 | 74 | 199 | 13 | 10817752 |
| Pubmed | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 PCDHB7 PCDHB4 PCDHB2 PCDHB18P PCDHGA12 PCDHGA8 | 6.32e-16 | 77 | 199 | 13 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 PCDHB7 PCDHB4 PCDHB2 PCDHB18P PCDHGA12 PCDHGA8 | 1.07e-15 | 80 | 199 | 13 | 10716726 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHB7 PCDHB4 PCDHB2 PCDHB18P PCDHGA12 | 3.89e-11 | 57 | 199 | 9 | 32633719 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHB4 TMEM67 RPN2 CD109 ITGA6 ITGA2 DRG1 FAT1 PXDN TM9SF2 PTPRF MRC2 DNAJC1 PIGO ABCC1 COL12A1 GLB1L2 LIFR PPP2R2A MEGF8 TENM3 LNPEP FURIN CD44 CD58 CD151 ATM CXADR | 3.15e-10 | 1201 | 199 | 28 | 35696571 |
| Pubmed | 1.67e-08 | 15 | 199 | 5 | 23515096 | ||
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 4.24e-08 | 58 | 199 | 7 | 30377227 | |
| Pubmed | RPN2 RGPD1 FNBP1L PXDN PREX1 MED13 RGPD5 RANBP2 RGPD8 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 APOB RNF2 SBNO1 PCDHGA12 MTTP PADI6 RAB1B ATM PCDHGA8 RBBP9 | 2.46e-07 | 1442 | 199 | 26 | 35575683 | |
| Pubmed | 4.36e-07 | 162 | 199 | 9 | 25826454 | ||
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 5.15e-07 | 28 | 199 | 5 | 15347688 | |
| Pubmed | Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. | 7.35e-07 | 4 | 199 | 3 | 20445537 | |
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 23071680 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 26481148 | ||
| Pubmed | Role for a novel Usher protein complex in hair cell synaptic maturation. | 7.35e-07 | 4 | 199 | 3 | 22363448 | |
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 33009420 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 9480752 | ||
| Pubmed | ZFYVE16 RPN2 ITGA6 PSMC4 WWC2 PTPRF ABCC1 RANBP2 PDPR PSD3 NBEA HUWE1 PPP2R2A NUP155 LNPEP CD44 PPP1R18 CDK5RAP2 CRYBG3 PLK4 CXADR | 7.43e-07 | 1049 | 199 | 21 | 27880917 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | CNTNAP3B PAQR5 ITGA6 PSMC4 PEX10 FAT1 TM9SF2 PTPRF MRC2 SYPL1 MUL1 PIGO ABCC10 PDPR APOB ACAD10 HUWE1 EFNB1 FURIN CD44 ATM | 8.91e-07 | 1061 | 199 | 21 | 33845483 |
| Pubmed | Functional significance of isoform diversification in the protocadherin gamma gene cluster. | 1.42e-06 | 34 | 199 | 5 | 22884324 | |
| Pubmed | EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. | 1.83e-06 | 5 | 199 | 3 | 11983165 | |
| Pubmed | Deletion of Rbpj from postnatal endothelium leads to abnormal arteriovenous shunting in mice. | 1.83e-06 | 5 | 199 | 3 | 25209249 | |
| Pubmed | Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. | 3.64e-06 | 6 | 199 | 3 | 15466160 | |
| Pubmed | 3.64e-06 | 6 | 199 | 3 | 9630219 | ||
| Pubmed | 3.77e-06 | 19 | 199 | 4 | 18206867 | ||
| Pubmed | 4.69e-06 | 20 | 199 | 4 | 11322959 | ||
| Pubmed | 5.28e-06 | 44 | 199 | 5 | 19029045 | ||
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 9037092 | ||
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 20058854 | ||
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 16059920 | ||
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 21205196 | ||
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 24403063 | ||
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 9990854 | ||
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 23536549 | ||
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 12191015 | ||
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 22821000 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 6.35e-06 | 7 | 199 | 3 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 6.35e-06 | 7 | 199 | 3 | 11353387 | |
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 30944974 | ||
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 6.35e-06 | 7 | 199 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 6.35e-06 | 7 | 199 | 3 | 17372272 | |
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 38657106 | ||
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 18949001 | ||
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 25187515 | ||
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 8603673 | ||
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 26632511 | ||
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 23818861 | ||
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 20682751 | ||
| Pubmed | Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus. | 8.46e-06 | 23 | 199 | 4 | 10708515 | |
| Pubmed | 1.01e-05 | 24 | 199 | 4 | 21633169 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.01e-05 | 8 | 199 | 3 | 21670213 | |
| Pubmed | Microarray-based mutation analysis of 183 Spanish families with Usher syndrome. | 1.01e-05 | 8 | 199 | 3 | 19683999 | |
| Pubmed | EphB3 marks delaminating endocrine progenitor cells in the developing pancreas. | 1.01e-05 | 8 | 199 | 3 | 22434763 | |
| Pubmed | 1.01e-05 | 8 | 199 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.01e-05 | 8 | 199 | 3 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.01e-05 | 8 | 199 | 3 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.01e-05 | 8 | 199 | 3 | 28745977 | |
| Pubmed | DNASE2B FAT1 SDK1 PCDHB2 NBEA APOB HUWE1 BTBD3 EFNB1 EFNB2 NUP155 TENM3 FURIN CD44 CDK5RAP2 CXADR | 1.16e-05 | 777 | 199 | 16 | 35844135 | |
| Pubmed | 1.51e-05 | 9 | 199 | 3 | 19956686 | ||
| Pubmed | 1.51e-05 | 9 | 199 | 3 | 28100513 | ||
| Pubmed | 1.51e-05 | 9 | 199 | 3 | 17887960 | ||
| Pubmed | 1.51e-05 | 9 | 199 | 3 | 33253166 | ||
| Pubmed | 1.51e-05 | 9 | 199 | 3 | 9733766 | ||
| Pubmed | 1.51e-05 | 9 | 199 | 3 | 28705869 | ||
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.51e-05 | 9 | 199 | 3 | 18394993 | |
| Pubmed | 1.51e-05 | 9 | 199 | 3 | 15599401 | ||
| Pubmed | 1.51e-05 | 9 | 199 | 3 | 11553612 | ||
| Pubmed | 1.51e-05 | 9 | 199 | 3 | 10601307 | ||
| Pubmed | 1.51e-05 | 9 | 199 | 3 | 11580899 | ||
| Pubmed | 1.51e-05 | 9 | 199 | 3 | 28877029 | ||
| Pubmed | Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy. | 1.61e-05 | 55 | 199 | 5 | 38945485 | |
| Pubmed | Extra-embryonic vasculature development is regulated by the transcription factor HAND1. | 1.91e-05 | 28 | 199 | 4 | 15073150 | |
| Pubmed | Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1. | 2.15e-05 | 10 | 199 | 3 | 24618850 | |
| Pubmed | 2.15e-05 | 10 | 199 | 3 | 12724416 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 2.15e-05 | 10 | 199 | 3 | 16332688 | |
| Pubmed | Tetraspanin CD151 promotes cell migration by regulating integrin trafficking. | 2.15e-05 | 10 | 199 | 3 | 17716972 | |
| Pubmed | EphB signaling regulates target innervation in the developing and deafferented auditory brainstem. | 2.15e-05 | 10 | 199 | 3 | 22021100 | |
| Pubmed | 2.15e-05 | 10 | 199 | 3 | 10323857 | ||
| Pubmed | EphB2 guides axons at the midline and is necessary for normal vestibular function. | 2.15e-05 | 10 | 199 | 3 | 10839360 | |
| Pubmed | 2.15e-05 | 10 | 199 | 3 | 27160050 | ||
| Pubmed | 2.15e-05 | 10 | 199 | 3 | 24239741 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 2.15e-05 | 10 | 199 | 3 | 8857542 | |
| Pubmed | 2.15e-05 | 10 | 199 | 3 | 21859863 | ||
| Pubmed | Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. | 2.94e-05 | 11 | 199 | 3 | 15875024 | |
| Pubmed | 2.94e-05 | 11 | 199 | 3 | 17069463 | ||
| Pubmed | 2.94e-05 | 11 | 199 | 3 | 34110283 | ||
| Pubmed | Strain background effects and genetic modifiers of hearing in mice. | 2.94e-05 | 11 | 199 | 3 | 16579977 | |
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 2.94e-05 | 11 | 199 | 3 | 35771867 | |
| Pubmed | Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers. | 3.26e-05 | 2 | 199 | 2 | 19356789 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 16867992 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 16407210 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 21575518 | ||
| Pubmed | EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment. | 3.26e-05 | 2 | 199 | 2 | 35725568 | |
| Pubmed | Using thermal scanning assays to test protein-protein interactions of inner-ear cadherins. | 3.26e-05 | 2 | 199 | 2 | 29261728 | |
| Pubmed | Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fates. | 3.26e-05 | 2 | 199 | 2 | 20379195 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 7507029 | ||
| Pubmed | Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency. | 3.26e-05 | 2 | 199 | 2 | 28738418 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 21940737 | ||
| Interaction | TAFA5 interactions | 1.66e-10 | 18 | 189 | 7 | int:TAFA5 | |
| Interaction | RYK interactions | EPHB4 FREM2 PTPRF SDK1 SDK2 PCDHGA7 PCDHGA6 PCDHGA5 FAT3 PCDHB2 LRRC4B IGDCC4 EFNB1 PCDHGA12 DSG4 | 1.58e-09 | 212 | 189 | 15 | int:RYK |
| Interaction | PCDHGA4 interactions | 2.48e-08 | 34 | 189 | 7 | int:PCDHGA4 | |
| Interaction | PCDHGA7 interactions | 9.59e-08 | 25 | 189 | 6 | int:PCDHGA7 | |
| Interaction | LGALS1 interactions | CD109 ITGA6 ITGA2 FREM2 MRC2 SDK1 SDK2 EMB FAT3 COP1 LRRC4B IGDCC4 TENM3 LNPEP CD44 CD151 | 1.03e-07 | 332 | 189 | 16 | int:LGALS1 |
| Interaction | LGALS8 interactions | 7.86e-07 | 174 | 189 | 11 | int:LGALS8 | |
| Interaction | ST8SIA4 interactions | 1.22e-06 | 84 | 189 | 8 | int:ST8SIA4 | |
| Interaction | UCN3 interactions | 2.02e-06 | 23 | 189 | 5 | int:UCN3 | |
| Interaction | PCDHGA5 interactions | 2.03e-06 | 63 | 189 | 7 | int:PCDHGA5 | |
| Interaction | PSG8 interactions | 2.15e-06 | 41 | 189 | 6 | int:PSG8 | |
| Interaction | SCGB1D1 interactions | 4.64e-06 | 133 | 189 | 9 | int:SCGB1D1 | |
| Interaction | TAFA2 interactions | 4.90e-06 | 47 | 189 | 6 | int:TAFA2 | |
| Interaction | PCDHGB1 interactions | 7.89e-06 | 77 | 189 | 7 | int:PCDHGB1 | |
| Interaction | PCDHGA8 interactions | 8.01e-06 | 5 | 189 | 3 | int:PCDHGA8 | |
| Interaction | FBXO2 interactions | EPHB4 CNTNAP3B CD109 ITGA6 ITGA2 ADGRV1 PXDN MRC2 SDK2 COL12A1 EMB LIFR MEGF8 TENM3 LNPEP | 8.20e-06 | 411 | 189 | 15 | int:FBXO2 |
| Interaction | TMPRSS11B interactions | CNTNAP3B TMEM67 RPN2 ITGA6 TM9SF2 PTPRF SLC25A11 DNAJC1 ABCC1 APOB GLB1L2 EFNB1 MEGF8 LNPEP CD151 | 9.47e-06 | 416 | 189 | 15 | int:TMPRSS11B |
| Interaction | HYOU1 interactions | TMEM67 RPN2 CD109 ADGRV1 FREM2 FAT1 SCNN1A SIRT7 TEK RNF2 TENM3 LNPEP FURIN | 9.81e-06 | 317 | 189 | 13 | int:HYOU1 |
| Interaction | BRICD5 interactions | EPHB4 TMEM67 ITGA6 ITGA2 TM9SF2 SDK2 HHLA2 EFNB1 FURIN CD151 | 1.54e-05 | 194 | 189 | 10 | int:BRICD5 |
| Interaction | H2BC5 interactions | PTPRF IPO8 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 HUWE1 SBNO1 PCDHGA12 PCDHGA8 | 1.55e-05 | 331 | 189 | 13 | int:H2BC5 |
| Interaction | DHFR2 interactions | CD109 PSMC4 ADGRV1 DRG1 ERFE FCER1A DNAJC1 PCDHGA9 HUWE1 LNPEP CDK5RAP2 CRYBG3 | 1.92e-05 | 289 | 189 | 12 | int:DHFR2 |
| Interaction | NPIPB6 interactions | 2.07e-05 | 18 | 189 | 4 | int:NPIPB6 | |
| Interaction | RGPD5 interactions | 3.37e-05 | 96 | 189 | 7 | int:RGPD5 | |
| Interaction | DIRAS3 interactions | ITGA6 ITGA2 ABCC1 IPO8 PSD3 NBEA HUWE1 EFNB1 EFNB2 LNPEP CXADR | 3.88e-05 | 262 | 189 | 11 | int:DIRAS3 |
| Interaction | RGPD4 interactions | 4.80e-05 | 22 | 189 | 4 | int:RGPD4 | |
| Interaction | SFTPC interactions | CNTNAP3B TMEM67 ITGA6 ITGA2 TM9SF2 SCNN1A GLB1L2 MEGF8 LNPEP CD151 | 4.86e-05 | 222 | 189 | 10 | int:SFTPC |
| Interaction | LOC254896 interactions | 4.96e-05 | 43 | 189 | 5 | int:LOC254896 | |
| Interaction | PCDHGB2 interactions | 5.55e-05 | 44 | 189 | 5 | int:PCDHGB2 | |
| Interaction | PCDHB3 interactions | 5.64e-05 | 141 | 189 | 8 | int:PCDHB3 | |
| Interaction | PCDHGA6 interactions | 6.87e-05 | 24 | 189 | 4 | int:PCDHGA6 | |
| Interaction | CD160 interactions | 8.49e-05 | 48 | 189 | 5 | int:CD160 | |
| Interaction | DKKL1 interactions | 8.53e-05 | 111 | 189 | 7 | int:DKKL1 | |
| Interaction | LGALS3 interactions | MYOC CD109 ITGA2 MRC2 SYPL1 SDK1 ABCC1 SDK2 EMB LNPEP CD44 CD58 | 9.24e-05 | 340 | 189 | 12 | int:LGALS3 |
| Interaction | PCDHGA12 interactions | 9.28e-05 | 10 | 189 | 3 | int:PCDHGA12 | |
| Interaction | RGPD1 interactions | 9.39e-05 | 49 | 189 | 5 | int:RGPD1 | |
| Interaction | SCGB1D4 interactions | 1.11e-04 | 27 | 189 | 4 | int:SCGB1D4 | |
| Interaction | RGPD2 interactions | 1.11e-04 | 27 | 189 | 4 | int:RGPD2 | |
| Interaction | LAMP1 interactions | GPR137 ZFYVE16 RPN2 NADK2 ITGA6 ITGA2 ABCC1 PSD3 NBEA HUWE1 EFNB1 EFNB2 TENM3 LNPEP CD44 RAB1B CXADR | 1.25e-04 | 644 | 189 | 17 | int:LAMP1 |
| Interaction | RHOB interactions | EPHB4 ZFYVE16 ITGA6 ITGA2 FAT1 PTPRF MRC2 SDK1 ABCC1 SDK2 PSD3 NBEA EFNB1 EFNB2 NUP155 TENM3 LNPEP CD44 ROBO2 CXADR | 1.28e-04 | 840 | 189 | 20 | int:RHOB |
| Interaction | CEACAM8 interactions | 1.32e-04 | 119 | 189 | 7 | int:CEACAM8 | |
| Interaction | TAFAZZIN interactions | 1.52e-04 | 207 | 189 | 9 | int:TAFAZZIN | |
| Interaction | RAC1 interactions | EPHB4 ZFYVE16 RPN2 ITGA6 ITGA2 FNBP1L FAT1 PTPRF MRC2 SLC25A11 PREX1 ABCC1 IPO8 PSD3 HUWE1 EFNB1 EFNB2 NUP155 LNPEP CD44 DSG4 RAB1B CXADR | 1.63e-04 | 1063 | 189 | 23 | int:RAC1 |
| Interaction | TAFA4 interactions | 1.64e-04 | 55 | 189 | 5 | int:TAFA4 | |
| Interaction | GML interactions | 2.11e-04 | 58 | 189 | 5 | int:GML | |
| Interaction | RAC2 interactions | EPHB4 ZFYVE16 RPN2 ITGA6 FAT1 PTPRF MRC2 SLC25A11 DNAJC1 ABCC1 PSD3 EFNB1 NUP155 TENM3 LNPEP CD44 CXADR | 2.15e-04 | 674 | 189 | 17 | int:RAC2 |
| Interaction | PCDHA9 interactions | 2.19e-04 | 32 | 189 | 4 | int:PCDHA9 | |
| Interaction | PI4K2B interactions | 2.47e-04 | 60 | 189 | 5 | int:PI4K2B | |
| Interaction | PCDHGA9 interactions | 2.48e-04 | 33 | 189 | 4 | int:PCDHGA9 | |
| Interaction | RAC3 interactions | EPHB4 ZFYVE16 ITGA6 ITGA2 FNBP1L FAT1 PTPRF ABCC1 PSD3 EFNB1 EFNB2 NUP155 TENM3 LNPEP CD44 CXADR | 2.52e-04 | 619 | 189 | 16 | int:RAC3 |
| Interaction | RHOQ interactions | EPHB4 ZFYVE16 ITGA6 ITGA2 FAT1 PTPRF ABCC1 PSD3 EFNB1 EFNB2 LNPEP CD44 CXADR | 2.87e-04 | 442 | 189 | 13 | int:RHOQ |
| Interaction | RAB2A interactions | EPHB4 TMEM67 RPN2 ITGA6 ITGA2 TM9SF2 PTPRF ABCC1 PSD3 NBEA EFNB1 EFNB2 LNPEP RAB1B CXADR | 3.08e-04 | 567 | 189 | 15 | int:RAB2A |
| Interaction | CCDC74A interactions | 3.13e-04 | 35 | 189 | 4 | int:CCDC74A | |
| Interaction | EPHB3 interactions | 3.13e-04 | 35 | 189 | 4 | int:EPHB3 | |
| Interaction | PRSS37 interactions | 3.40e-04 | 15 | 189 | 3 | int:PRSS37 | |
| Interaction | CERS5 interactions | 3.49e-04 | 36 | 189 | 4 | int:CERS5 | |
| Cytoband | 5q31 | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 WNT8A PCDHB7 PCDHB4 PCDHB2 PCDHB18P PCDHGA12 PCDHGA8 | 1.26e-16 | 115 | 199 | 14 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 WNT8A PCDHB7 PCDHB4 PCDHB2 PCDHB18P PCDHGA12 PCDHGA8 | 6.51e-11 | 298 | 199 | 14 | chr5q31 |
| Cytoband | 18q12.1 | 1.94e-04 | 26 | 199 | 3 | 18q12.1 | |
| Cytoband | 22q12.3 | 3.98e-04 | 33 | 199 | 3 | 22q12.3 | |
| Cytoband | 5q14 | 8.22e-04 | 10 | 199 | 2 | 5q14 | |
| GeneFamily | Clustered protocadherins | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 PCDHB7 PCDHB4 PCDHB2 PCDHB18P PCDHGA12 PCDHGA8 | 6.72e-15 | 64 | 154 | 13 | 20 |
| GeneFamily | Fibronectin type III domain containing | EPHB4 EPOR PTPRF SDK1 SDK2 COL12A1 MID2 TEK IGDCC4 LIFR ROBO2 | 1.25e-07 | 160 | 154 | 11 | 555 |
| GeneFamily | Cadherin related | 2.39e-07 | 17 | 154 | 5 | 24 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.21e-06 | 161 | 154 | 10 | 593 | |
| GeneFamily | ATP binding cassette subfamily C | 1.63e-04 | 13 | 154 | 3 | 807 | |
| GeneFamily | Immunoglobulin like domain containing | 2.52e-04 | 193 | 154 | 8 | 594 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 4.28e-04 | 4 | 154 | 2 | 649 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 5.69e-04 | 394 | 154 | 11 | 471 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 7.09e-04 | 5 | 154 | 2 | 1086 | |
| GeneFamily | Desmosomal cadherins | 1.47e-03 | 7 | 154 | 2 | 1188 | |
| GeneFamily | Cytochrome P450 family 3 | 1.95e-03 | 8 | 154 | 2 | 1002 | |
| GeneFamily | Ephrins | 1.95e-03 | 8 | 154 | 2 | 546 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 2.50e-03 | 9 | 154 | 2 | 973 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 3.81e-03 | 37 | 154 | 3 | 454 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | EPHB4 TTYH1 ADGRV1 FREM2 FAT1 PREX1 IL33 FAT3 PSD3 S1PR1 IGDCC4 TENM3 IQCA1 CD44 | 6.97e-07 | 364 | 196 | 14 | M39057 |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 2.73e-06 | 199 | 196 | 10 | M7319 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | TTYH1 NADK2 ITGA6 ADGRV1 TTR FREM2 FAT1 MRC2 PLEKHH2 PREX1 IL33 FAT3 LIFR IQCA1 CD44 MTTP | 7.29e-06 | 574 | 196 | 16 | M39056 |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | CD109 SIDT1 ITGA6 FAT1 PXDN SCNN1A SDK1 SLC27A2 PRSS35 ABCC1 SDK2 MID2 PCDHB7 PSD3 NBEA SHROOM2 EFNB2 HMCN1 CD44 | 7.70e-06 | 786 | 196 | 19 | M10961 |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 3.42e-05 | 164 | 196 | 8 | M41676 | |
| Coexpression | AIZARANI_LIVER_C10_MVECS_1 | EPHB4 CNTNAP3B ITGA6 IL33 ADAMTS1 TEK S1PR1 LIFR EFNB1 EFNB2 | 3.76e-05 | 269 | 196 | 10 | M39114 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_1000 | APH1B MARS1 PAQR5 ITGA6 HMGCS1 EYA3 MEF2C PTH1R SYPL1 PIGO SLC27A2 IPO8 NRDC EMB SLC5A1 SBNO1 ATM PLK4 CXADR | 4.51e-05 | 761 | 187 | 19 | gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_1000 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | EPHB4 FNBP1L PXDN IL33 COL12A1 MID2 ADAMTS1 TEK S1PR1 BTBD3 LIFR EFNB2 HMCN1 CD151 | 4.79e-05 | 450 | 187 | 14 | GSM777063_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | CD109 ITGA6 HMGCS1 ITGA2 MEF2C PXDN DPPA5 PRSS35 MID2 ADAMTS1 FAT3 TEK SHROOM2 SLA S1PR1 BTBD3 LIFR EFNB2 HMCN1 ROBO2 | 6.02e-05 | 846 | 187 | 20 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_100 | 7.71e-05 | 10 | 187 | 3 | gudmap_kidney_P1_CapMes_Crym_k2_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_500 | CD109 ITGA6 ITGA2 MEF2C PXDN MID2 TEK SHROOM2 S1PR1 BTBD3 EFNB2 HMCN1 CRYBG3 | 8.58e-05 | 416 | 187 | 13 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-vs-F_top274_274 | 9.50e-05 | 256 | 187 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EPHB4 ITGA6 FNBP1L PXDN MID2 ADAMTS1 TEK S1PR1 BTBD3 LIFR EFNB2 HMCN1 | 8.34e-11 | 194 | 199 | 12 | f159ef8541d75a4e98468947f231bb463bec922c |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | CD109 ITGA6 FNBP1L ABCC8 PCDH15 PREX1 UNC13B TEK LIFR EFNB1 CD44 | 1.53e-09 | 197 | 199 | 11 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-08 | 184 | 199 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-08 | 184 | 199 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-08 | 184 | 199 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | CDH23 ITGA2 PTH1R SVEP1 PCDH15 PLEKHH2 SDK1 ADAMTS1 HMCN1 ROBO2 | 1.31e-08 | 187 | 199 | 10 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte-7|World / Primary Cells by Cluster | 1.52e-08 | 190 | 199 | 10 | 8f1c490dd8e5f80382f5294fd1aa8cba4c3c647f | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte|World / Primary Cells by Cluster | 1.52e-08 | 190 | 199 | 10 | 7dbfd543398c63cbe1e68b54bcb5e2291f521935 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.60e-08 | 191 | 199 | 10 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-08 | 192 | 199 | 10 | 1990dc8a81594018a5bf596be99d0b5f0af0f58f | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PCSK1 TM9SF2 ABCC8 SDK2 EMB GLB1L2 TENM3 PITPNM3 NIPAL1 ROBO2 | 1.68e-08 | 192 | 199 | 10 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-08 | 192 | 199 | 10 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-08 | 192 | 199 | 10 | 845cc9c18b4436b07dd3ce7980052683937546d2 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-08 | 192 | 199 | 10 | c72a082c93a8825adbfef37f889ba3a7052f201b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.77e-08 | 193 | 199 | 10 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | ITGA2 PTH1R SVEP1 PCDH15 PLEKHH2 SDK1 FAT3 HMCN1 TENM3 ROBO2 | 1.77e-08 | 193 | 199 | 10 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.77e-08 | 193 | 199 | 10 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | EPHB4 ITGA6 FNBP1L SYPL1 ADAMTS1 TEK S1PR1 EFNB1 EFNB2 HMCN1 | 1.85e-08 | 194 | 199 | 10 | 2c78e754cac848fd47172f94e392749eb0ab50d4 |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | EPHB4 ITGA6 FNBP1L SYPL1 ADAMTS1 TEK S1PR1 EFNB1 EFNB2 HMCN1 | 1.85e-08 | 194 | 199 | 10 | 92a8e6e3e3f6fd9dacb723b58e7a8b63473e403e |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.85e-08 | 194 | 199 | 10 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-08 | 195 | 199 | 10 | 65fc50e3818e902028fc4226070fa57609c66b9c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | ITGA2 PTH1R SVEP1 PCDH15 PLEKHH2 SDK1 ADAMTS1 FAT3 HMCN1 ROBO2 | 1.95e-08 | 195 | 199 | 10 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-08 | 195 | 199 | 10 | 3b79e6bb525b17192ecec9e1227a29c419968144 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.25e-08 | 198 | 199 | 10 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PTH1R SVEP1 MRC2 PCDH15 PLEKHH2 SDK1 SDK2 ADAMTS1 IGDCC4 TENM3 | 2.36e-08 | 199 | 199 | 10 | 8b86c69aaf60feff53aa782559cfece7342a23de |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | PTH1R SVEP1 FAT1 PRSS35 COL12A1 FAT3 IGDCC4 LIFR TENM3 ROBO2 | 2.36e-08 | 199 | 199 | 10 | bf138cc692df727e087d140c014149ee5da00d9d |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | PTH1R SVEP1 FAT1 PRSS35 COL12A1 FAT3 IGDCC4 LIFR TENM3 ROBO2 | 2.36e-08 | 199 | 199 | 10 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | PTH1R SVEP1 MRC2 PLEKHH2 SDK1 ADAMTS1 FAT3 HMCN1 TENM3 ROBO2 | 2.36e-08 | 199 | 199 | 10 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-08 | 199 | 199 | 10 | f0bf75bfae7b288ecb6801be458b03ebd0108ea7 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Radial_glial|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.36e-08 | 199 | 199 | 10 | 0fee11bd72b27202f8d9fa4daba831ea9c8a61b2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ITGA2 PTH1R SVEP1 PCDH15 PLEKHH2 SDK1 FAT3 HMCN1 TENM3 ROBO2 | 2.48e-08 | 200 | 199 | 10 | 34f52003988ce6329d8deeee1ab875fa77e01e9d |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.48e-08 | 200 | 199 | 10 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.48e-08 | 200 | 199 | 10 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-08 | 200 | 199 | 10 | 90061284a80d29a4ca6078f578e13d32b8cc80e1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-07 | 178 | 199 | 9 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.20e-07 | 179 | 199 | 9 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-07 | 187 | 199 | 9 | 52ffd4be374e329ac8d321063f061b826d252956 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 1.74e-07 | 187 | 199 | 9 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-07 | 189 | 199 | 9 | 25db316f66cee53774bb2b286cc457b37353356c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-07 | 190 | 199 | 9 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-07 | 190 | 199 | 9 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 1.99e-07 | 190 | 199 | 9 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.99e-07 | 190 | 199 | 9 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-07 | 190 | 199 | 9 | e64b191f928935484e2c993d7f8af0572a617a3a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-07 | 191 | 199 | 9 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-07 | 191 | 199 | 9 | 9fc674a58f20b47255e4457d5195c8cff17b0414 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-07 | 191 | 199 | 9 | c379a499dabf3c9ed80f47adbb2d949821c5b053 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.08e-07 | 191 | 199 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.17e-07 | 192 | 199 | 9 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.17e-07 | 192 | 199 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.17e-07 | 192 | 199 | 9 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.17e-07 | 192 | 199 | 9 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-07 | 192 | 199 | 9 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.27e-07 | 193 | 199 | 9 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.27e-07 | 193 | 199 | 9 | 4b8202fcfe639a73f69a13f48fc3601ade256346 | |
| ToppCell | droplet-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-07 | 194 | 199 | 9 | ff076902578997565d72dc40b0b80ae76d6ab2b4 | |
| ToppCell | droplet-Lung-1m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-07 | 194 | 199 | 9 | 1ac52b00ea0b0ddbd04f5d85fa8c086980a78926 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-07 | 194 | 199 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia|World / Primary Cells by Cluster | 2.37e-07 | 194 | 199 | 9 | 1445b7611c2b1ab9b320f330d17d70117892cc28 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|COPD / Disease state, Lineage and Cell class | 2.37e-07 | 194 | 199 | 9 | 18b7f901c12ca4f21f9a1eafd092aefe4d668b6d | |
| ToppCell | droplet-Lung-18m-Endothelial-capillary_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-07 | 194 | 199 | 9 | 627432da2e00dc4256f48a6388ce78e7b5e7a51e | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 2.37e-07 | 194 | 199 | 9 | 68705a6eca947c5b42b943d5224a7aef2a744007 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-07 | 194 | 199 | 9 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-07 | 194 | 199 | 9 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-07 | 194 | 199 | 9 | fc3f81b5bdc544a69c355e482f002643e029a7b0 | |
| ToppCell | droplet-Lung-18m-Endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-07 | 194 | 199 | 9 | fd4548db0f12170b636186e6af90666f7e26c0ad | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.48e-07 | 195 | 199 | 9 | 98dd3b7d5ef587825dac052dea4d4ff883f6d4d6 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-07 | 195 | 199 | 9 | f65053811074a7f2ff0368f3a63b88e2a08da1a0 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 2.48e-07 | 195 | 199 | 9 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.48e-07 | 195 | 199 | 9 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | droplet-Lung-30m-Endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.59e-07 | 196 | 199 | 9 | 58871891185aa7e1e4ab9b99cd25c1ca3c932cc8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.59e-07 | 196 | 199 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.59e-07 | 196 | 199 | 9 | 9e737eaa98fd49972fce64d1d4a4d1f34b9bcb96 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 2.59e-07 | 196 | 199 | 9 | 8f0f72ead06abe02b575e443552eacc2151077ef | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.59e-07 | 196 | 199 | 9 | 99a7f2e57774884216525897dcd32a289107548b | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.59e-07 | 196 | 199 | 9 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.70e-07 | 197 | 199 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.70e-07 | 197 | 199 | 9 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.82e-07 | 198 | 199 | 9 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Capillary-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.94e-07 | 199 | 199 | 9 | 993999adf346b4fd557989bc53c17eb0ccb996c9 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Capillary|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.94e-07 | 199 | 199 | 9 | 89f4db619fbed90f7fdf6ece7a671e514b5c6d76 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Capillary|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.94e-07 | 199 | 199 | 9 | 3fea92affacd4c1f588fa81807df35d6c69b7241 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Macroglial-Astrocyte|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.07e-07 | 200 | 199 | 9 | 29f82e2ad2f1888b6b236a4392b88a84351b8ddc | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.07e-07 | 200 | 199 | 9 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.07e-07 | 200 | 199 | 9 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | proximal-3-Endothelial-Bronchial_Vessel_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-07 | 200 | 199 | 9 | 0ff4185021ec84b57be13b28495e2f8a4d195eb6 | |
| ToppCell | proximal-Endothelial-Bronchial_Vessel_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-07 | 200 | 199 | 9 | e4f6e0b9502eb531f28d605f9dbda6a72a9ed320 | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-07 | 200 | 199 | 9 | 707148e01e961097819a05437a842b7d3bf72b0a | |
| ToppCell | medial-2-Endothelial-Capillary_Intermediate_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-07 | 200 | 199 | 9 | a8adf5902540f6bb15b72efbb9c389b59d67e001 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-07 | 200 | 199 | 9 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial-Astrocyte|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.07e-07 | 200 | 199 | 9 | 98d7f577b31a603bf835bf9b4ea31999445cf0e5 | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-07 | 200 | 199 | 9 | 3ef7b7728615710c691aed8977e2582f19692cf9 | |
| ToppCell | proximal-Endothelial-Bronchial_Vessel_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-07 | 200 | 199 | 9 | d034bd210c87b704acf45f50d888497c8737011b | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Basal_3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.07e-07 | 200 | 199 | 9 | 06b59ee536414d1f73c1e17cdfd7c3f2259b9bef | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Macroglial|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.07e-07 | 200 | 199 | 9 | 1598a9e8efa72fda7d12df07e7716b326cdf1d5e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.07e-07 | 200 | 199 | 9 | 38b51f337e183011e3ff32997ec26d8a424c6b78 | |
| ToppCell | (01)_IL1RL1+|World / shred by cell type by condition | 3.07e-07 | 200 | 199 | 9 | 501420901bf3ec1b050e0d14596a9f9f3fdfc928 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.07e-07 | 200 | 199 | 9 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.55e-07 | 153 | 199 | 8 | b37a1ecad389d2848b8ca4d287823e8048207420 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.78e-07 | 154 | 199 | 8 | ea5d0da5dd8ccfc19969aec35f044db77d589f54 | |
| Disease | mental development measurement | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 PCDHGA8 | 2.41e-12 | 25 | 189 | 8 | EFO_0008230 |
| Disease | childhood trauma measurement, alcohol consumption measurement | ITGA6 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8 | 3.01e-11 | 71 | 189 | 10 | EFO_0007878, EFO_0007979 |
| Disease | Sarcosine measurement | 5.88e-09 | 23 | 189 | 6 | EFO_0021668 | |
| Disease | Disorder of eye | TMEM67 MYOC CDH23 ADGRV1 FREM2 PCDH15 IMPG2 EYS BBS7 PITPNM3 MTTP | 1.36e-07 | 212 | 189 | 11 | C0015397 |
| Disease | lymphocyte count | TTYH1 CYP3A7 CYP3A5 CDH23 PTH1R TM9SF2 PREX1 TTF2 ABCC1 ZAN PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 PSD3 WDR27 ACAD10 S1PR1 ZNF710 SBNO1 PCDHGA12 ROBO2 ATM PCDHGA8 | 7.72e-07 | 1464 | 189 | 27 | EFO_0004587 |
| Disease | mean platelet volume | SIDT1 ITGA6 ITGA2 MEF2C SVEP1 ZAN NRDC PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA2 PCDHGA1 PSD3 ZNF710 PCDHGA12 CD151 PADI6 PCDHGA8 | 9.72e-06 | 1020 | 189 | 20 | EFO_0004584 |
| Disease | Usher syndrome, type 1D | 4.08e-05 | 2 | 189 | 2 | C2931208 | |
| Disease | USHER SYNDROME, TYPE ID | 4.08e-05 | 2 | 189 | 2 | C1832845 | |
| Disease | USHER SYNDROME, TYPE ID | 4.08e-05 | 2 | 189 | 2 | 601067 | |
| Disease | Usher syndrome type 1D | 4.08e-05 | 2 | 189 | 2 | cv:C1832845 | |
| Disease | Usher syndrome type 1D (is_implicated_in) | 4.08e-05 | 2 | 189 | 2 | DOID:0110831 (is_implicated_in) | |
| Disease | hyperinsulinism (is_implicated_in) | 5.45e-05 | 12 | 189 | 3 | DOID:2018 (is_implicated_in) | |
| Disease | Ciliopathies | 7.87e-05 | 110 | 189 | 6 | C4277690 | |
| Disease | trichothiodystrophy (is_implicated_in) | 1.22e-04 | 3 | 189 | 2 | DOID:0111866 (is_implicated_in) | |
| Disease | tacrolimus measurement | 2.43e-04 | 4 | 189 | 2 | EFO_0008458 | |
| Disease | Usher syndrome, type 1A | 4.03e-04 | 5 | 189 | 2 | C2931205 | |
| Disease | Hydrophthalmos | 4.03e-04 | 5 | 189 | 2 | C0020302 | |
| Disease | USHER SYNDROME, TYPE IB (disorder) | 4.03e-04 | 5 | 189 | 2 | C1848638 | |
| Disease | USHER SYNDROME, TYPE IA, FORMERLY | 4.03e-04 | 5 | 189 | 2 | C1848639 | |
| Disease | USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY | 4.03e-04 | 5 | 189 | 2 | C1848640 | |
| Disease | Usher syndrome type 1 | 4.03e-04 | 5 | 189 | 2 | cv:C1568247 | |
| Disease | Alzheimer disease, polygenic risk score | EPHB4 FSIP2 PXDN SDK1 ZAN EMB PCDHGA5 PCDHGA2 PCDHGA1 PSD3 SBNO1 CEACAM16 | 4.25e-04 | 586 | 189 | 12 | EFO_0030082, MONDO_0004975 |
| Disease | Liver Cirrhosis, Experimental | ZFYVE16 MYOC FAT1 ADIPOQ PXDN IL33 COL12A1 EMB NBEA SLA S1PR1 PPP1R18 ROBO2 CXADR | 4.96e-04 | 774 | 189 | 14 | C0023893 |
| Disease | FEV change measurement, response to zileuton | 5.36e-04 | 25 | 189 | 3 | EFO_0005921, EFO_0007676 | |
| Disease | X-11423--O-sulfo-L-tyrosine measurement | 6.02e-04 | 6 | 189 | 2 | EFO_0021231 | |
| Disease | Neonatal Alloimmune Thrombocytopenia | 6.02e-04 | 6 | 189 | 2 | C3853779 | |
| Disease | FNAITP | 6.02e-04 | 6 | 189 | 2 | C3854603 | |
| Disease | Usher Syndrome, Type I | 6.02e-04 | 6 | 189 | 2 | C1568247 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 6.03e-04 | 26 | 189 | 3 | C0009405 | |
| Disease | complement factor H-related protein 3 measurement | 7.96e-04 | 169 | 189 | 6 | EFO_0600056 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 8.36e-04 | 29 | 189 | 3 | C1333990 | |
| Disease | Hereditary retinal dystrophy | 8.39e-04 | 7 | 189 | 2 | C0154860 | |
| Disease | Usher syndrome | 8.39e-04 | 7 | 189 | 2 | cv:C0271097 | |
| Disease | glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement | 1.11e-03 | 8 | 189 | 2 | EFO_0800533 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 1.32e-03 | 74 | 189 | 4 | DOID:3748 (is_marker_for) | |
| Disease | response to alcohol | 1.39e-03 | 75 | 189 | 4 | EFO_0005526 | |
| Disease | Lynch Syndrome | 1.43e-03 | 9 | 189 | 2 | C4552100 | |
| Disease | cardiovascular system disease (is_marker_for) | 1.78e-03 | 10 | 189 | 2 | DOID:1287 (is_marker_for) | |
| Disease | cystic kidney disease (implicated_via_orthology) | 1.78e-03 | 10 | 189 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Peripheral T-Cell Lymphoma | 1.78e-03 | 10 | 189 | 2 | C0079774 | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 1.78e-03 | 10 | 189 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | Nonsyndromic Deafness | 1.85e-03 | 81 | 189 | 4 | C3711374 | |
| Disease | Colorectal Carcinoma | CD109 LRRC4 FAT1 ABCC8 PIGO UNC13B ABCC1 SLC66A2 APOB LIFR MLH3 TP63 | 1.99e-03 | 702 | 189 | 12 | C0009402 |
| Disease | mean corpuscular hemoglobin concentration | MEF2C ERFE PREX1 PIGO MED13 ABCC10 IMPG2 ABCC1 PCDHGA5 TMPRSS6 PSD3 ACAD10 RHCE IGDCC4 BBS7 PLK4 | 2.09e-03 | 1105 | 189 | 16 | EFO_0004528 |
| Disease | brain infarction (implicated_via_orthology) | 2.16e-03 | 11 | 189 | 2 | DOID:3454 (implicated_via_orthology) | |
| Disease | cortical thickness | SIDT1 FNBP1L ADGRV1 MEF2C PTPRF PKD1 ABCC10 COL12A1 FAT3 SLA AGBL4 PPP2R2A EFNB2 FURIN CDK5RAP2 ROBO2 | 2.25e-03 | 1113 | 189 | 16 | EFO_0004840 |
| Disease | stomach cancer (is_marker_for) | 2.26e-03 | 142 | 189 | 5 | DOID:10534 (is_marker_for) | |
| Disease | facial height measurement | 2.26e-03 | 142 | 189 | 5 | EFO_0007856 | |
| Disease | initial pursuit acceleration | 2.40e-03 | 87 | 189 | 4 | EFO_0008434 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma | 2.47e-03 | 42 | 189 | 3 | EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354 | |
| Disease | disks large homolog 3 measurement | 2.58e-03 | 12 | 189 | 2 | EFO_0802472 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.03e-03 | 152 | 189 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | triacylglycerol 54:4 measurement | 3.21e-03 | 46 | 189 | 3 | EFO_0010422 | |
| Disease | Mammary Neoplasms, Experimental | 3.29e-03 | 155 | 189 | 5 | C0024668 | |
| Disease | end stage renal disease (biomarker_via_orthology) | 3.41e-03 | 47 | 189 | 3 | DOID:783 (biomarker_via_orthology) | |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 3.53e-03 | 14 | 189 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | gamma-glutamylglutamate measurement | 3.53e-03 | 14 | 189 | 2 | EFO_0021137 | |
| Disease | 1-methylurate measurement | 3.53e-03 | 14 | 189 | 2 | EFO_0021173 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 4.06e-03 | 15 | 189 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | infant head circumference | 4.06e-03 | 15 | 189 | 2 | EFO_0004577 | |
| Disease | response to platinum based chemotherapy, magnesium measurement | 4.06e-03 | 15 | 189 | 2 | EFO_0004647, EFO_0004845 | |
| Disease | diabetic retinopathy (is_implicated_in) | 4.06e-03 | 50 | 189 | 3 | DOID:8947 (is_implicated_in) | |
| Disease | ceramide measurement | 4.18e-03 | 235 | 189 | 6 | EFO_0010222 | |
| Disease | brain ischemia (biomarker_via_orthology) | 4.25e-03 | 102 | 189 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 4.30e-03 | 51 | 189 | 3 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | vision disorder | 4.62e-03 | 16 | 189 | 2 | MONDO_0021084 | |
| Disease | transferrin saturation measurement | 4.62e-03 | 16 | 189 | 2 | EFO_0006333 | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 4.62e-03 | 16 | 189 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | Cannabis use | 4.62e-03 | 16 | 189 | 2 | EFO_0007585 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 4.62e-03 | 16 | 189 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | fatty liver disease (is_marker_for) | 5.21e-03 | 17 | 189 | 2 | DOID:9452 (is_marker_for) | |
| Disease | Vitiligo | 5.21e-03 | 17 | 189 | 2 | C0042900 | |
| Disease | glutarylcarnitine (C5-DC) measurement | 5.21e-03 | 17 | 189 | 2 | EFO_0800030 | |
| Disease | Adenomatous Polyposis Coli | 5.21e-03 | 17 | 189 | 2 | C0032580 | |
| Disease | ecosanoids measurement | 5.31e-03 | 55 | 189 | 3 | EFO_0020044 | |
| Disease | aortic measurement | 5.73e-03 | 251 | 189 | 6 | EFO_0020865 | |
| Disease | noggin measurement | 5.84e-03 | 18 | 189 | 2 | EFO_0021995 | |
| Disease | Age-related macular degeneration | 5.84e-03 | 18 | 189 | 2 | cv:C0242383 | |
| Disease | Bardet-Biedl syndrome | 5.84e-03 | 18 | 189 | 2 | cv:C0752166 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 5.84e-03 | 18 | 189 | 2 | DOID:0080208 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TQEETGLSSDILSYY | 286 | Q9H313 | |
| SSYYGINLASAFIIL | 206 | Q8WW43 | |
| LSYASDLYNGSSIVS | 411 | Q8NHY2 | |
| ISITNATVEDSGTYY | 161 | P12319 | |
| ISGSDLFLSASYIYN | 116 | Q8IWZ6 | |
| YSAPLIVTSSSNSVY | 2431 | Q7Z408 | |
| GTSVTNLLYPTTSYL | 1096 | Q68DQ2 | |
| NSISINSDYETYLSA | 181 | P63151 | |
| TYTEYLSATTNITPL | 691 | Q8IZF6 | |
| SLTNYATSLNTPVSY | 1806 | Q8IZF6 | |
| YRSAFSVGLETYVTI | 111 | Q15848 | |
| GYETTSSVLSFTLYE | 306 | P20815 | |
| VSYLVASYIVSTGDE | 61 | Q2WEN9 | |
| YASGTGYVLSASAVQ | 261 | O96024 | |
| SDEYEVSISYAVTTG | 296 | Q8WXG9 | |
| SYSYDSSEVSLQTGL | 171 | P11230 | |
| YKRSLTGQASSTYAE | 566 | Q6JQN1 | |
| FYTASVILDGNELSY | 466 | Q9Y2F9 | |
| ESSDLTEVVVYGSYL | 61 | A6NC42 | |
| STGLIITVNYLDYET | 1261 | Q9H251 | |
| LETTYIQSYDHGTSI | 291 | Q96KC8 | |
| GEYSYLGTTLRQVSI | 521 | Q86XH1 | |
| ESFSLYSDQTSYLSI | 621 | Q96SN8 | |
| TSSVYGSLASVLAQY | 346 | Q01581 | |
| SLVTYYTSSGEDILI | 796 | Q8TDY8 | |
| DTYTESYISTIGVDF | 31 | Q9H0U4 | |
| LTVATTGPSVYYSQS | 866 | P49792 | |
| EGSLSVLGYSVLYSS | 191 | Q13258 | |
| VSSYVSINSDTGVLY | 501 | Q9Y5G6 | |
| LSSYISINSDTGVLY | 501 | Q9Y5H1 | |
| ITSASYYATVTLDQV | 116 | Q5T6V5 | |
| LTVATTGPSVYYSQS | 866 | Q99666 | |
| LTVATTGPSVYYSQS | 866 | O14715 | |
| TYILNGDYTLSTLEQ | 776 | Q9UHI8 | |
| YSYPIQASSTNASLI | 161 | Q99504 | |
| YEKVSYVSGSSLLTT | 231 | Q9NV88 | |
| LSSYVSINSDTGVLY | 501 | Q9Y5G8 | |
| LSSYISINSDTGVLY | 501 | Q9Y5G5 | |
| LSSYVSINSDTGVLY | 501 | O60330 | |
| SINSDTGVLYALSSF | 506 | O60330 | |
| YISETVSIYLGLSQV | 161 | Q99742 | |
| VSGTGTLSQSYQYEV | 741 | Q9Y5E7 | |
| VSGTGTLSQSYQYEV | 686 | Q96TA0 | |
| YYVALAVLNTILSTG | 151 | Q9NXK6 | |
| TTLAGYQTLGEEYVS | 61 | O60683 | |
| YAIVLVSAYTSDLGD | 91 | O75884 | |
| YLVTETYSASGSLVQ | 931 | P32926 | |
| NYLLTITATDGTFSS | 2991 | Q14517 | |
| IEYSVYLAIQSSQAG | 1921 | P51610 | |
| FYLTVYATIAGVNSL | 966 | Q5T3U5 | |
| SAEFSGLISYSVSLV | 266 | Q6TGC4 | |
| QYSVGALYTTSTDKT | 396 | Q5XUX1 | |
| DTSQYEYTVLLSGLI | 206 | Q8NG84 | |
| LSSYVSINSDTGILY | 501 | Q9Y5G7 | |
| SLYTIGSIISAAVYL | 136 | Q9H511 | |
| YQERGTSYLLSSSAV | 346 | P28336 | |
| VYLDTVSGSLTIYNL | 81 | P19256 | |
| ELSSGHYYTIVTLSV | 96 | P04201 | |
| GVYSEVAAYEFTTLT | 86 | Q9Y295 | |
| SVVYSYNLGSGIASI | 2486 | Q5T1H1 | |
| TYTFEVTALNGVSSL | 401 | P54760 | |
| GIADASNLSYYVEVT | 161 | Q2M2H8 | |
| GESLSSRASYYEISV | 281 | Q4G0N4 | |
| AVTLGLTAAYTTLYA | 21 | Q96N19 | |
| TGTVPTSVLSYSDYI | 1926 | Q5SZK8 | |
| SSLLNYVLGTYTAID | 401 | Q86SJ6 | |
| SSEIYTNTYAAGGTV | 711 | Q86SJ6 | |
| QSLVSGELESSSYSY | 5071 | Q5CZC0 | |
| DYYIISTSNGSLEGL | 131 | P52799 | |
| YILEGYSITDNSAAS | 1671 | Q96RV3 | |
| SAGTTVTVYNLFYQL | 141 | Q9UHC1 | |
| RSASTYSLDILYSGS | 626 | P55157 | |
| LSTYVSINSDTGVLY | 501 | Q9Y5G4 | |
| SSYISINSDTGVLYA | 506 | Q9Y5H3 | |
| VGKTTSSAYSYSLER | 796 | Q8NCN5 | |
| SSSELFTISVNGVLY | 306 | Q4G0M1 | |
| GTFSVLAYYLSSSQN | 266 | Q9UM44 | |
| TFGAVDLYVSTSYDT | 2496 | Q7Z7M0 | |
| YFAYTVGLSLLTAIS | 106 | Q8TDS7 | |
| LYTVSSYTSADATVN | 436 | Q99972 | |
| GTTSVVTAALYSVYR | 16 | Q969V5 | |
| TGYQPAYTTSTTVLI | 481 | Q9HBW1 | |
| EQTYINGLLTGYSST | 281 | Q9UBG0 | |
| YTIQNIVAGSTYLFS | 961 | Q9UIQ6 | |
| STTYGTEYSLSSADL | 316 | Q06413 | |
| SYLGLLFLTSVSYTD | 256 | P23229 | |
| SSLAFTTGSYVYIIS | 206 | Q8NGM8 | |
| ATLIANYSYTVGQSE | 2086 | Q7Z6Z7 | |
| YLGYSVAAISTGEST | 436 | P17301 | |
| NSAATLSYTTSGLYT | 576 | Q8IVE3 | |
| STVFLYLTGNNISYI | 61 | Q7Z2Q7 | |
| QATYTTTRLGIYTVL | 91 | Q02978 | |
| YSLPTDNTYLLTITS | 206 | O75694 | |
| YAYSTRLFTIDGISI | 5021 | Q96RW7 | |
| DYELTSSYSLIVQAT | 2306 | Q6V1P9 | |
| VDVSGTGTLSQSYQY | 736 | Q9Y5E5 | |
| LNLYTGSVASYELTQ | 11 | A0A075B6J6 | |
| YTVNLNTYTATDTKG | 1576 | Q460N5 | |
| SYYATVNELTPVGTT | 151 | Q96QU1 | |
| DLSGTGTLSQSYQYE | 736 | Q9Y5E2 | |
| TTQGLTTIYQIEHYS | 566 | Q9H3D4 | |
| AYTRSVATSSIVGYI | 2851 | Q13315 | |
| SREYSGTIASEANTY | 3506 | P04114 | |
| NYTLALITYALSSVG | 1086 | Q6YHK3 | |
| ISPITEYLASLSTYN | 116 | O95760 | |
| EYLASLSTYNDQSIT | 121 | O95760 | |
| SGETGLEYLYLDSTT | 56 | Q8WZ79 | |
| YSQHIYRTISDGTIS | 286 | Q5T0N5 | |
| NTGVYILTSNTSQYD | 101 | P16070 | |
| GTQYALSVTALYASG | 876 | Q99715 | |
| SILSGSLDYSYSPVQ | 41 | A8K830 | |
| DITTLITYVSALSYG | 251 | Q9BPX7 | |
| DGYTNSIYTLSISSA | 306 | P09958 | |
| VISVKNASSEYSGTY | 196 | P78310 | |
| DYYITSTSNGSLEGL | 131 | P98172 | |
| TYSLYSEASVSVADL | 2636 | Q8TDW7 | |
| EVSFYSYIISGTTAA | 401 | Q5VU57 | |
| YLVVSDSGISTDYSS | 456 | P19235 | |
| QSFGYILYETSITSS | 426 | Q8IW92 | |
| ENNYLVSATGSTLYT | 111 | Q6PCB8 | |
| VSATGSTLYTQYRFT | 116 | Q6PCB8 | |
| SYASQQSKISGYSTE | 231 | Q5T9C2 | |
| YSLYAAVSVGLQTSD | 121 | P19447 | |
| GYETTSSVLSFIIYE | 306 | P24462 | |
| NSLTVVLSTDYANSY | 241 | Q86UP6 | |
| SYTSIYAENINTTSL | 261 | Q86UP6 | |
| SDYISLLASGTYLAT | 46 | P48509 | |
| SLYTYLSAEFIGTAT | 61 | P0C6P0 | |
| GYVTSVLQYENSITL | 266 | Q7Z3Z3 | |
| ALETTYQYPSESSVL | 546 | Q6NYC8 | |
| LVILATTTSDAGAYY | 246 | Q7Z5N4 | |
| LEYRVTGLTALTTYT | 951 | Q58EX2 | |
| VAYTANLLLSGATTY | 96 | P21453 | |
| LYKYSSFTTLVAGSR | 161 | P37088 | |
| VIFATYSSLIGESQS | 396 | A3KN83 | |
| YSLYVGLVLAVSSSI | 66 | Q6NVV3 | |
| YTIYIATASGQFTVL | 291 | Q99496 | |
| SEVVYFDGQSALLYT | 181 | Q96NU0 | |
| ISILTAQYTTSYDPE | 16 | P02748 | |
| ATSYTLVESFSGKYV | 366 | P42702 | |
| SGGYTYFTTVTVETL | 481 | Q9NT99 | |
| TAYNTDYQLTSAELS | 331 | Q14814 | |
| FGYISNYTVSTKVAS | 2836 | P98161 | |
| TTYSVTVAAYTTKGD | 791 | P10586 | |
| LTVATTGPSVYYSQS | 851 | P0DJD0 | |
| LSAYLSINSDTGVLY | 501 | Q9Y5H4 | |
| DYASPTTAAQTLLYT | 386 | O15397 | |
| SFSSVLYYGNEATLL | 926 | Q5HYA8 | |
| YSSSQDALISVSYTI | 266 | Q6IF99 | |
| GLSVSYSLQVTTYLN | 1231 | P33527 | |
| ALLVSISNTYGLDYV | 76 | P03901 | |
| SYGLRESIASYLSLT | 226 | Q13239 | |
| VLIGDYSSSAQFYVT | 106 | Q16563 | |
| SNAFSYYGLVLLTTE | 326 | Q8N4V2 | |
| TTGSNYYVRILSTID | 106 | P43686 | |
| DVSIYYVSRTSNTDG | 176 | O14975 | |
| LYTYLSAEFIGTATI | 616 | Q8NFP9 | |
| LSYTSVRSNSSYLGS | 1181 | Q8TCU6 | |
| VPAAVSLATNSTYYS | 1386 | Q13796 | |
| YTTTGGLASVIYTDT | 191 | Q9NY91 | |
| YLVVYTGAGISTAAS | 101 | Q9NRC8 | |
| PSTSLIYDSDLAVSY | 766 | Q9UHV7 | |
| SYTQTSGALVVFFSL | 891 | Q9BZV3 | |
| VLQISSDGNTITIYY | 636 | O00444 | |
| YILSGLTYLSTASYS | 1916 | Q4LDE5 | |
| IDVQGLAYLSTALYT | 2451 | Q4LDE5 | |
| TFLQASYYVAIETGI | 371 | Q09428 | |
| SQNTTYLYASFLTTV | 361 | Q7RTR0 | |
| AGYEIITNTLSFATY | 341 | P24557 | |
| LNSLSSTELYYSSQS | 461 | Q6AWC2 | |
| GSVLTLAGVSIYISY | 136 | A6NFC5 | |
| TYYALAVSVVTAISG | 241 | P18577 | |
| YTVGYSVSLASLTVA | 191 | Q03431 | |
| ALNTYYSLAASTLGT | 251 | Q9H310 | |
| TNLESAFYSIVGLSS | 46 | P04844 | |
| EFDSASGTYTLYLII | 471 | P04844 | |
| SGTYTLYLIIGDATL | 476 | P04844 | |
| STSSLSNYLYVFILG | 221 | Q6ZQN7 | |
| VYSGVVNLSTENIYS | 51 | Q9NXL6 | |
| YLSYETVFENGTRTL | 81 | Q8N3Z0 | |
| LTSYIDASNVYGSTE | 906 | Q92626 | |
| SQQLVYTLLGIYTGS | 196 | Q86WB7 | |
| YSYASVDSSAEASVL | 636 | Q8N1W2 | |
| YSVFSISITLTDEGY | 501 | O43847 | |
| FLTVEYGTILSSANS | 456 | Q8IYQ7 | |
| TAIAVSYSGVLYITE | 1406 | Q9P273 | |
| GAIYSSIDFTTKTSY | 971 | Q9HCK4 | |
| SLRYALSLYTQTTDT | 1386 | O14795 | |
| AIESLNYSVYTTNSD | 1006 | Q02763 | |
| SAAYGSTKDISVYSV | 836 | Q9BZ71 | |
| NDGIIYSTSLTFTYT | 431 | Q06330 | |
| SESYQQGVLSATILY | 271 | P0DTU4 | |
| QITGTASTILYFGYT | 616 | Q99805 | |
| ESLNVIYVGSYSGTS | 866 | Q8NB50 | |
| LTVAAYQLGSVYSAA | 821 | Q8TEQ8 | |
| TIAALLSPYSYSTTA | 126 | P02766 | |
| YLTYTTSVALGAQSG | 36 | Q9H1J5 | |
| TGSLIYSSSVLSAYP | 196 | A2RRH5 | |
| TGLSSEYQIDTTYVP | 621 | O60294 | |
| ISSYELQYTIFTGQA | 431 | Q9UJV3 | |
| YTITGGLAAVIYTDT | 191 | P13866 | |
| ETILDNTSLYYSAES | 446 | Q9NYI0 | |
| LLYISSSQTTDSGVY | 91 | A0A0B4J277 | |
| ATIGYLSITANYTDQ | 521 | P56192 | |
| VAGYITYLSIDSALF | 156 | Q8N2U9 | |
| VDTTLSDSYNYSGTE | 211 | Q7Z3T8 | |
| ITSTRLGTYYNSSSV | 126 | Q8IU80 | |
| LSTYDIVITTYSLVA | 686 | Q9UNY4 | |
| QSSLYLTASQLSYSG | 91 | A0A087WSZ9 | |
| GDQQLYVTVSSTYSG | 1271 | Q9Y493 | |
| SYSSYQGIIATSLLN | 156 | Q01538 | |
| GYTDSIYTISISSAS | 321 | P29120 | |
| LATSYSSGDYTDQRI | 351 | P29120 |